Sonia Gavasso

677 total citations
26 papers, 300 citations indexed

About

Sonia Gavasso is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Sonia Gavasso has authored 26 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Immunology and 7 papers in Oncology. Recurrent topics in Sonia Gavasso's work include Single-cell and spatial transcriptomics (5 papers), Multiple Sclerosis Research Studies (5 papers) and Advanced Biosensing Techniques and Applications (4 papers). Sonia Gavasso is often cited by papers focused on Single-cell and spatial transcriptomics (5 papers), Multiple Sclerosis Research Studies (5 papers) and Advanced Biosensing Techniques and Applications (4 papers). Sonia Gavasso collaborates with scholars based in Norway, United States and Sweden. Sonia Gavasso's co-authors include Christian A. Vedeler, Bjørn Tore Gjertsen, Kjell‐Morten Myhr, Jørn Skavland, Nello Blaser, André Sulen, Christopher Elnan Kvistad, Clara Gram Gjesdal, Brith Bergum and Roland Jonsson and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Sonia Gavasso

26 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sonia Gavasso Norway 12 102 90 68 58 45 26 300
Timothy Weeden Slovakia 7 155 1.5× 101 1.1× 64 0.9× 41 0.7× 34 0.8× 8 336
Peiwen Kuo United States 8 179 1.8× 93 1.0× 18 0.3× 99 1.7× 36 0.8× 16 370
Edoardo Pedrini Italy 12 208 2.0× 83 0.9× 55 0.8× 44 0.8× 10 0.2× 23 356
Hui Gao China 12 125 1.2× 30 0.3× 98 1.4× 68 1.2× 55 1.2× 45 451
Shenyi Jiang China 12 149 1.5× 89 1.0× 19 0.3× 101 1.7× 43 1.0× 22 371
Ankush Bhatia United States 10 71 0.7× 47 0.5× 40 0.6× 60 1.0× 37 0.8× 23 417
Ehsan Ghayoor Karimiani Iran 12 180 1.8× 123 1.4× 37 0.5× 47 0.8× 16 0.4× 46 476
Weiping Li China 9 86 0.8× 80 0.9× 96 1.4× 64 1.1× 74 1.6× 22 323
Max Kaufmann Germany 9 163 1.6× 184 2.0× 132 1.9× 101 1.7× 22 0.5× 18 486
Jenni Virta Finland 12 127 1.2× 58 0.6× 16 0.2× 44 0.8× 18 0.4× 31 390

Countries citing papers authored by Sonia Gavasso

Since Specialization
Citations

This map shows the geographic impact of Sonia Gavasso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonia Gavasso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonia Gavasso more than expected).

Fields of papers citing papers by Sonia Gavasso

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonia Gavasso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonia Gavasso. The network helps show where Sonia Gavasso may publish in the future.

Co-authorship network of co-authors of Sonia Gavasso

This figure shows the co-authorship network connecting the top 25 collaborators of Sonia Gavasso. A scholar is included among the top collaborators of Sonia Gavasso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonia Gavasso. Sonia Gavasso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gavasso, Sonia, et al.. (2024). The Therapeutic Potential of Exosomes from Mesenchymal Stem Cells in Multiple Sclerosis. International Journal of Molecular Sciences. 25(19). 10292–10292. 4 indexed citations
2.
Gavasso, Sonia, et al.. (2024). The Therapeutic Mechanisms of Mesenchymal Stem Cells in MS—A Review Focusing on Neuroprotective Properties. International Journal of Molecular Sciences. 25(3). 1365–1365. 17 indexed citations
3.
Kvistad, Christopher Elnan, et al.. (2024). Neural regeneration in the human central nervous system—from understanding the underlying mechanisms to developing treatments. Where do we stand today?. Frontiers in Neurology. 15. 1398089–1398089. 10 indexed citations
4.
Blaser, Nello, et al.. (2022). GUBS: Graph-Based Unsupervised Brain Segmentation in MRI Images. Journal of Imaging. 8(10). 262–262. 4 indexed citations
5.
Gavasso, Sonia, et al.. (2022). Brain Tumor Segmentation Based on Minimum Spanning Tree. SHILAP Revista de lepidopterología. 2. 9 indexed citations
7.
Vedeler, Christian A., Kristian Hovde Liland, Anette McLeod, et al.. (2021). Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis. Scientific Reports. 11(1). 4087–4087. 15 indexed citations
8.
Blaser, Nello, et al.. (2021). Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic. Journal of the Neurological Sciences. 429. 117622–117622. 8 indexed citations
9.
Myhr, Kjell‐Morten, et al.. (2020). Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study. Journal of the Neurological Sciences. 415. 116880–116880. 9 indexed citations
10.
Blaser, Nello, et al.. (2020). Wearing-off at the end of natalizumab dosing intervals is associated with low receptor occupancy. Neurology Neuroimmunology & Neuroinflammation. 7(3). 17 indexed citations
11.
Blaser, Nello, Morten Brun, André Sulen, et al.. (2019). Candidate Markers for Stratification and Classification in Rheumatoid Arthritis. Frontiers in Immunology. 10. 1488–1488. 18 indexed citations
12.
Davies, Richard, Irene Sarkar, Daniel Hammenfors, et al.. (2019). Single Cell Based Phosphorylation Profiling Identifies Alterations in Toll-Like Receptor 7 and 9 Signaling in Patients With Primary Sjögren's Syndrome. Frontiers in Immunology. 10. 281–281. 24 indexed citations
13.
Hellesøy, Monica, et al.. (2019). Titrating Complex Mass Cytometry Panels. Cytometry Part A. 95(7). 792–796. 14 indexed citations
14.
Blaser, Nello, Monica Hellesøy, Jørn Skavland, et al.. (2018). A 36-Dimensional Cytometry by Time of Flight (CyTOF) Analysis of De Novo Acute Myeloid Leukemia (AML) Patients Eligible for Intensive Chemotherapy. Blood. 132(Supplement 1). 1502–1502. 1 indexed citations
15.
Davies, Richard, Tim D. Holmes, Sonia Gavasso, et al.. (2017). Phosphorylation of intracellular signalling molecules in peripheral blood cells from patients with psoriasis on originator or biosimilar infliximab. British Journal of Dermatology. 179(2). 371–380. 6 indexed citations
16.
Sulen, André, et al.. (2016). Signaling effects of sodium hydrosulfide in healthy donor peripheral blood mononuclear cells. Pharmacological Research. 113(Pt A). 216–227. 14 indexed citations
18.
Gavasso, Sonia, et al.. (2012). Fcγ receptors in Norwegian multiple sclerosis patients and healthy controls. Acta Neurologica Scandinavica. 126. 84–89. 2 indexed citations
19.
Gavasso, Sonia, K-M Myhr, & Christian A. Vedeler. (2006). Multiplexed phosphoprotein analysis in immune cells. Acta Neurologica Scandinavica. 113(s183). 58–60. 2 indexed citations
20.
Gavasso, Sonia, Ottar Nygård, Eva Ringdal Pedersen, et al.. (2005). Fcγ receptor IIIA polymorphism as a risk-factor for coronary artery disease. Atherosclerosis. 180(2). 277–282. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026